High-density lipoprotein induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through sphingosine kinase-2

Molecular and Cellular Biochemistry

Volumn 389, Issue 1-2, 2014, Pages 197-207

  Xiong, Sheng Lin ^a   Liu, Xing ^b   Yi, Guang Hui ^b  

^a You Country People's Hospital   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Cyclooxygenase 2; High density lipoprotein; Protein kinase C; Sphingosine 1 phosphate; Sphingosine kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; PROSTACYCLIN; PROTEIN KINASE C; SPHINGOSINE KINASE 2;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; STIMULATION; UMBILICAL VEIN ENDOTHELIAL CELL;

CELLS, CULTURED; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; EPOPROSTENOL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, HDL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE C; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84896543456     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1941-y     Document Type: Article

References (39)

1. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res 95:764-772 (Pubitemid 39390578)
2. Thiemermann C (1991) Biosynthesis and interaction of endothelium-derived vasoactive mediators. Eicosanoids 4:187-202
3. Linton MF, Fazio S (2002) Cyclooxygenase-2 and atherosclerosis. Curr Opin Lipidol 13:497-504 (Pubitemid 35231929)
4. Vinals M, Martinez-Gonzalez J, Badimon JJ, Badimon L (1997) HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol 17:3481-3488 (Pubitemid 28028559)
5. Gonzalez-Diez M, Rodriguez C, Badimon L, Martinez-Gonzalez J (2008) Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. Thromb Haemost 100:119-126 (Pubitemid 351948753)
6. Norata GD, Callegari E, Inoue H, Catapano AL (2004) HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler Thromb Vasc Biol 24:871-877 (Pubitemid 38620865)
7. Bolli R, Shinmura K, Tang XL, Kodani E, Xuan YT, Guo Y, Dawn B (2002) Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 55:506-519 (Pubitemid 34874945)
8. Hanel P, Andreani P, Graler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21:1202-1209 (Pubitemid 46495709)
9. Dahm F, Nocito A, Bielawska A, Lang KS, Georgiev P, Asmis LM, Bielawski J, Madon J, Hannun YA, Clavien PA (2006) Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. J Thromb Haemost 4:2704-2709 (Pubitemid 44741568)
10. von Otte S, Paletta JR, Becker S, Konig S, Fobker M, Greb RR, Kiesel L, Assmann G, Diedrich K, Nofer JR (2006) Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem 281:5398-5405 (Pubitemid 43847634)
11. Kimura T, Sato K, Malchinkhuu E, Tomura H, Tamama K, Kuwabara A, Murakami M, Okajima F (2003) High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol 23:1283-1288 (Pubitemid 36871285)
12. Tamama K, Tomura H, Sato K, Malchinkhuu E, Damirin A, Kimura T, Kuwabara A, Murakami M, Okajima F (2005) High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis 178:19-23 (Pubitemid 39600811)
13. Oskeritzian CA, Alvarez SE, Hait NC, Price MM, Milstien S, Spiegel S (2008) Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. Blood 111:4193-4200
14. Spiegel S, Milstien S (2007) Functions of the multifaceted family of sphingosine kinases and some close relatives. J Biol Chem 282:2125-2129 (Pubitemid 47076736)
15. Liu H, Chakravarty D, Maceyka M, Milstien S, Spiegel S (2002) Sphingosine kinases: a novel family of lipid kinases. Prog Nucleic Acid Res Mol Biol 71:493-511
16. Nava VE, Lacana E, Poulton S, Liu H, Sugiura M, Kono K, Milstien S, Kohama T, Spiegel S (2000) Functional characterization of human sphingosine kinase-1. FEBS Lett 473:81-84 (Pubitemid 30235190)
17. Melendez AJ, Carlos-Dias E, Gosink M, Allen JM, Takacs L (2000) Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 251:19-26 (Pubitemid 30339413)
18. Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277:35257-35262
19. Serrano-Sanchez M, Tanfin Z, Leiber D (2008) Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2. Endocrinology 149:4669-4679
20. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254-1257
21. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H, Payne SG, Bektas M, Ishii I, Chun J, Milstien S, Spiegel S (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278:40330-40336 (Pubitemid 37248601)
22. Guo CM, Kasaraneni N, Sun K, Myatt L (2012) Cross talk between PKC and CREB in the induction of COX-2 by PGF2alpha in human amnion fibroblasts. Endocrinology 153:4938-4945
23. Hait NC, Sarkar S, Le Stunff H, Mikami A, Maceyka M, Milstien S, Spiegel S (2005) Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J Biol Chem 280:29462-29469 (Pubitemid 41177019)
24. Keating JA, Bhattacharya D, Lim PY, Falk S, Weisblum B, Bernard KA, Sharma M, Kuhn RJ, Striker R (2013) West Nile virus methyltransferase domain interacts with protein kinase G. Virol J 10:242
25. Chang YJ, Wu MS, Lin JT, Chen CC (2005) Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 175:8242-8252
26. Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P (2001) Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 254:183-190 (Pubitemid 32530758)
27. Martinez-Gonzalez J, Escudero I, Badimon L (2004) Simvastatin potenciates PGI(2) release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL. Atherosclerosis 174:305-313 (Pubitemid 38597087)
28. Mazurais D, Robert P, Gout B, Berrebi-Bertrand I, Laville MP, Calmels T (2002) Cell type-specific localization of human cardiac S1P receptors. J Histochem Cytochem 50:661-670
29. Montminy MR, Gonzalez GA, Yamamoto KK (1990) Regulation of cAMP-inducible genes by CREB. Trends Neurosci 13:184-188 (Pubitemid 20145139)
30. Gordon DJ, Rifkind BM (1989) High-density lipoprotein - the clinical implications of recent studies. N Engl J Med 321:1311-1316 (Pubitemid 19267219)
31. Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352-1364 (Pubitemid 43948059)
32. Keul P, Sattler K, Levkau B (2007) HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev 12:301-306 (Pubitemid 350176703)
33. Okazaki H, Ishizaka N, Sakurai T, Kurokawa K, Goto K, Kumada M, Takuwa Y (1993) Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem Biophys Res Commun 190:1104-1109 (Pubitemid 23207879)
34. Damirin A, Tomura H, Komachi M, Tobo M, Sato K, Mogi C, Nochi H, Tamoto K, Okajima F (2005) Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells. Mol Pharmacol 67:1177-1185 (Pubitemid 40410417)
35. Martinez-Gonzalez J, Rodriguez-Rodriguez R, Gonzalez-Diez M, Rodriguez C, Herrera MD, Ruiz-Gutierrez V, Badimon L (2008) Oleanolic acid induces prostacyclin release in human vascular smooth muscle cells through a cyclooxygenase-2-dependent mechanism. J Nutr 138:443-448 (Pubitemid 351355238)
36. Waeber C, Blondeau N, Salomone S (2004) Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. Drug News Perspect 17:365-382 (Pubitemid 39295641)
37. Okada T, Ding G, Sonoda H, Kajimoto T, Haga Y, Khosrowbeygi A, Gao S, Miwa N, Jahangeer S, Nakamura S (2005) Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J Biol Chem 280:36318-36325 (Pubitemid 41633905)
38. Hait NC, Bellamy A, Milstien S, Kordula T, Spiegel S (2007) Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J Biol Chem 282:12058-12065 (Pubitemid 47100715)
39. Johannessen M, Delghandi MP, Moens U (2004) What turns CREB on? Cell Signal 16:1211-1227 (Pubitemid 39165450)